diamicron mr 30 mg modified-release tablets
les laboratoires servier - gliclazide - modified-release tablet - 30 milligram(s) - sulfonamides, urea derivatives; gliclazide
pharmacor gliclazide gliclazide 30 mg modified release tablet blister pack
pharmacor pty ltd - gliclazide, quantity: 30 mg - tablet, modified release - excipient ingredients: mannitol; hypromellose; sodium acetate; magnesium stearate; lactose monohydrate; silicon dioxide - type ii diabetes in association with dietary measures when dietary measures alone are inadequate to control blood glucose.,during controlled clinical trials in patients with type ii diabetes, a modified release formulation of gliclazide (30 mg - 120 mg), taken as a single daily dose, was shown to be effective long term in controlling blood glucose levels, based on monitoring of hba1c.
apo-metformin xr 500 metformin hydrochloride 500 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.
apo-metformin xr 1000 metformin hydrochloride 1000 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.
blooms the chemist metformin xr 500 metformin hydrochloride 500 mg modified release tablet blister pack
gm pharma international pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.
blooms the chemist metformin xr 1000 metformin hydrochloride 1000 mg modified release tablet blister pack
gm pharma international pty ltd - metformin hydrochloride, quantity: 1000 mg - tablet, modified release - excipient ingredients: povidone; colloidal anhydrous silica; hypromellose; magnesium stearate - treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. metformin modified release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.
bilxona 60mg modified-release tablets
actavis group ptc ehf - gliclazide - modified-release tablet - 60mg - blood glucose lowering drugs, excl. insulins: sulfonylureas - non insulin-dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose
bilxona 30mg modified-release tablets
actavis group ptc ehf - gliclazide - modified-release tablet - 30mg - a10bb09 - non insulin-dependent diabetes (type 2) in adults when dietary measures, physical exercise and weight loss alone are not sufficient to control blood glucose
bilxona 30mg modified-release tablets
accord-uk ltd - gliclazide - modified-release tablet - 30mg
bilxona 60mg modified-release tablets
accord-uk ltd - gliclazide - modified-release tablet - 60mg